BiotechTube

palifosfamide

Phase 2Terminated
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adult Central Nervous System Germ Cell Tumor

Conditions

Adult Central Nervous System Germ Cell Tumor, Adult Teratoma, Malignant Extragonadal Germ Cell Tumor, Malignant Extragonadal Non-Seminomatous Germ Cell Tumor, Extragonadal Seminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor

Trial Timeline

Feb 1, 2013 → Nov 1, 2014

NCT ID
NCT01808534

About palifosfamide

palifosfamide is a phase 2 stage product being developed by Alaunos Therapeutics for Adult Central Nervous System Germ Cell Tumor. The current trial status is terminated. This product is registered under clinical trial identifier NCT01808534. Target conditions include Adult Central Nervous System Germ Cell Tumor, Adult Teratoma, Malignant Extragonadal Germ Cell Tumor.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT01703754Phase 2Terminated
NCT01808534Phase 2Terminated

Competing Products

20 competing products in Adult Central Nervous System Germ Cell Tumor

See all competitors
ProductCompanyStageHype Score
BBP-398 + sotorasibBridgeBio PharmaPhase 1
30
Daridorexant + PlaceboIdorsiaPhase 1
28
SON-1010 (IL12-FHAB)Sonnet BioTherapeuticsPhase 1
28
SomatropinEli LillyPhase 3
77
agenT-797MiNK TherapeuticsPhase 1
25
PegilodecakinEli LillyPhase 1
33
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + TrastuzumabeFFECTOR TherapeuticsPhase 1/2
33
Lazertinib(G001) + Lazertinib(G002)YuhanPhase 1
33
Patritumab deruxtecanDaiichi SankyoPhase 2
52
DJ-927 + capecitabineDaiichi SankyoPhase 1
33
Valemetostat TosylateDaiichi SankyoPhase 2
52
RoxadustatAstellas PharmaPhase 1
33
ASP3325 + PlaceboAstellas PharmaPhase 1
33
TRK-100STPAstellas PharmaPhase 1
33
EnsitrelvirShionogiPhase 1
33
E6130 + PlaceboEisaiPhase 1
33
E7389 + E7389 + E7389EisaiPhase 1
33
Eribulin MesylateEisaiPhase 1
33
E2022 + E2022 + E2022 + E2022 + E2022EisaiPhase 1
33
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
33

Other Products from Alaunos Therapeutics

doxorubicin in combination with palifosfamide-tris + doxorubicin in combination with placeboPhase 3
69
Carboplatin + Palifosfamide-tris + Etoposide + CarboplatinPhase 3
69
Palifosfamide Tris and Doxorubicin + DoxorubicinPhase 2
44
Ad-RTS-hIL-12 + Veledimex + Cemiplimab-RwlcPhase 2
44
DarinaparsinPhase 2
44